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Abstract
The focus of this study is the development of a statistical modelling procedure
for characterising intra-tumour heterogeneity, motivated by recent clinical
literature indicating that a variety of tumours exhibit a considerable degree of
genetic spatial variability. A formal spatial statistical model has been developed
and used to characterise the structural heterogeneity of a number of
supratentorial primitive neuroectodermal tumours (PNETs), based on
diffusion-weighted magnetic resonance imaging. Particular attention is paid to
the spatial dependence of diffusion close to the tumour boundary, in order to
determine whether the data provide statistical evidence to support the
proposition that water diffusivity in the boundary region of some tumours
exhibits a deterministic dependence on distance from the boundary, in excess
of an underlying random 2D spatial heterogeneity in diffusion. Tumour spatial
heterogeneity measures were derived from the diffusion parameter estimates
obtained using a Bayesian spatial random effects model. The analyses were
implemented using Markov chain Monte Carlo (MCMC) simulation. Posterior
predictive simulation was used to assess the adequacy of the statistical model.
The main observations are that the previously reported relationship between
diffusion and boundary proximity remains observable and achieves statistical
significance after adjusting for an underlying random 2D spatial heterogeneity
in the diffusion model parameters. A comparison of the magnitude of the
boundary-distance effect with the underlying random 2D boundary
heterogeneity suggests that both are important sources of variation in the
vicinity of the boundary. No consistent pattern emerges from a comparison of
the boundary and core spatial heterogeneity, with no indication of a consistently
greater level of heterogeneity in one region compared with the other. The
results raise the possibility that DWI might provide a surrogate marker of
intra-tumour genetic regional heterogeneity, which would provide a powerful
tool with applications in both patient management and in cancer research.
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Introduction
Numerous investigations have demonstrated a surprising level of 
intra-tumour heterogeneity in a variety of cancers1–3. In particular, 
a picture is emerging in which intra-tumour genetic regional dif-
ferences can be as great as those observed between cases. It has 
become widely accepted that spatial heterogeneity underlies the 
tumour evolutionary process itself. Thus, tumour growth is con-
ceived as a Darwinian process in which spatially heterogeneous 
mutations occur. The implications are enormous, and intra-tumour 
heterogeneity poses challenges and questions for those searching 
for effective treatments. For example, it has been suggested that 
drug resistance is an inevitable consequence of intra-tumour genetic 
diversity, and that the presence of many different genomes increases 
the probability that a particular population of cells develop resist-
ance. It is also suggested that a given drug might kill a majority of 
tumour cells, leaving those that are resistant to become dominant 
in a Darwinian-like selection processes. Thus, according to this 
proposition, selection is driven by the treatment itself. Furthermore, 
clinical decision making and patient management based on a stand-
ard biopsy must be questionable and the very notion of personalised 
medicine might be a greater challenge than initially conceived. The 
realisation that treatment can drive the evolutionary process might 
indicate a need to revise current treatment strategies4.
Many papers have appeared in the biomedical imaging literature 
dealing with tumour spatial heterogeneity and proposing a variety 
of methods for characterising the resulting distributions. Quantile 
estimates are commonly used for this purpose, but a variety of other 
methods have been adopted including, for example, measures based 
on the departure of the observed data from a simple idealised spa-
tial structure5 and functional principal components analysis6. A key 
feature of the majority of these analyses is their two-stage nature 
in which voxel-by-voxel parameter estimates are derived from the 
image data, followed by a second-stage analysis of the resulting 
parameter distribution. The present paper outlines a single-stage 
approach to characterising tumour heterogeneity in DWI images 
based on so-called random effects modelling. A key feature of the 
method is that a formal spatial model is included in the statistical 
procedure used to extract the diffusion parameter estimates from 
the signal intensity data. In fact, given the paucity of the DWI data 
used in the present analyses, the spatial random effects treatment is 
an indispensable component of the estimation method.
A key tenet underlying the application of diffusion MRI (dMRI) 
to cancer patient management is the notion that the apparent diffu-
sion coefficient (ADC) is a surrogate marker of altered cellularity. 
Despite numerous investigations into the relationship between cel-
lularity and MRI surrogate markers7–14 several issues remain to be 
resolved. One might question whether positive tests of association, 
including correlation coefficient tests, are sufficient to justify the 
surrogate-marker claim. A relatively weak relationship can be suffi-
cient to yield a statistically significant test result. It might be argued 
that the requirements of a biomarker/surrogate marker should meet 
the criteria of a surrogate endpoint in clinical trials (see, for exam-
ple, 15). Secondly, some of the published evidence is based on 
statistical models that might be judged inadmissible. Furthermore, 
some researchers use p-values as the sole supporting evidence 
of biomarker validity. Although p-values may provide a measure 
of the strength of evidence (recognising that this contravenes the 
rules governing the frequentist approach to statistical inference), 
a p-value does not provide a measure of the strength of the effect/
association under consideration (see, for example, 16). Among the 
complications is the p-value dependence on sample size. Moreover, 
the p-value provided by an association test does not address the key 
issues of specificity and sensitivity.
Working under the assumption that the ADC is a valid surrogate 
marker of cellularity, researchers have focussed on a variety of 
tumour ADC measures, including various global spatial heteroge-
neity and dispersion/distribution indicators (see, for example 9 or 
17). Some have examined the spatial dependence of the ADC in 
the vicinity of the tumour boundary (see, for example, 14, or 17) 
while others have focussed their efforts on the elucidation of the 
underlying causes of the diffusion changes11,18, or have adopted an 
entirely empirical approach and examined the relationship between 
survival and one or other DWI measure19–22. The latter studies aim 
to address the central clinical issue and provide a direct answer to 
the fundamental question regarding the prognostic/diagnostic value 
of dMRI. This literature provided the motivation for the present 
statistical modelling work. Although the mechanistic basis of the 
ADC changes that occur during tumour development may remain 
elusive, this does not preclude the possibility that dMRI might have 
the potential to provide a useful prognostic indicator. In keeping 
with this empirical approach, the present study was undertaken to 
develop a formal statistical modelling procedure for tumour DWI 
spatial heterogeneity estimation. The main focus is robust voxel-
specific ADC estimation and an examination of the ADC depend-
ence on distance from the tumour boundary. This is prompted by a 
number of reports indicating that some tumours exhibit a boundary- 
distance dependence in ADC, the magnitude of which might carry 
prognostic information14,17,22. In particular, we examine the magni-
tude and significance of the boundary-distance effect that remains 
after simultaneously adjusting for an underlying random 2D hetero-
geneity in ADC. In addition, heterogeneity in the boundary region 
is compared with that in the core. As stated above, this is based on 
the premise that empirical measures might provide useful prognos-
tic information in the absence of an understanding of the mechanis-
tic basis of the spatial variation and temporal changes in diffusion 
that have been observed to occur in a variety of tumours.
Bayesian random effect models and Markov chain Monte 
Carlo simulation
The tumour heterogeneity analysis outlined in this paper is based 
on a Bayesian spatial random effects (random coefficients) analy-
sis of paediatric DWI data. Key to this approach is the provision 
of robust estimates of the voxel-specific diffusion parameters, as 
required to obtain reliable measures of spatial heterogeneity. The 
random coefficient estimates are expected to be more robust than 
the voxel-specific parameter estimates provided by an independent- 
voxels (separate voxel-by-voxel) analysis. In common with all 
Bayesian analyses, prior distributions are a central part of the sta-
tistical model. These provide a formal mechanism for incorporat-
ing existing information and model assumptions. In the present 
study Markov random field prior distributions were adopted for a 
number of parameters, including the voxel-specific anisotropic dif-
fusion coefficients, as outlined below and in the Methods section. 
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The reason why Bayesian random effect models have the potential 
to provide improved parameter estimates, relative to those given 
by an independent-voxels analysis, is because they make good 
use of the available data through so-called information borrow-
ing. In the present context, the signal behaviour in adjacent voxels 
influences the parameter estimates obtained for each voxel under 
consideration. Formal borrowing of information across a region 
and the resulting improvement in estimation is mediated via the 
prior distributions that are assigned to each model parameter. 
Restated, the distributional priors underlie the information bor-
rowing that is key to random effects modelling. (The distributional 
assumptions required to construct an hierarchical random effects 
model are priors, by definition, regardless of the analytical frame-
work, be it frequentist or Bayesian.) The resulting estimators are 
referred to as shrinkage estimators, the aim being to provide some 
shrinkage towards the typical behaviour, and thus achieve some 
level of smoothing. Specifically, shrinkage refers to the condition 
where more extreme estimates are pulled towards more typical 
values, as determined by the distribution characteristics (spatial 
correlation structure in the present application) of the ensemble of 
units (voxels in the present study) under consideration. More robust 
estimates of the underlying and unknown parameters are thus 
obtained, improving on those that might be derived from an 
independent units (isolated voxel-by-voxel) analysis. Necessar-
ily, one accepts a trade-off between bias and improved variance. 
Nevertheless, in any situation in which there is a true, non-negligible 
underlying variation between the units under consideration, com-
bined with a non-negligible measurement error, neither completely- 
pooled estimation (averaging over the ROI) nor the estimates 
obtained through a set of separate analyses are uncompromised. 
This issue is discussed in Sections 5.4 and 5.5 of the textbook by 
Gelman et al.23, where they use a simple dataset to compare the 
results given by a random effects treatment with the completely 
pooled result and an independent units analysis. They make a 
convincing case for random effects modelling.
Among the research disciplines in which Bayesian spatial random 
effects modelling is especially prominent is epidemiological dis-
ease mapping. Disease mapping and the present tumour heteroge-
neity study share a similar objective, namely the extraction of an 
underlying spatial structure, given data that are typically corrupted 
by noise. Sparseness/rarity of the observed events is a problem in 
some disease mapping applications, which is not dissimilar to the 
sparse data problem that arises in the present study. Markov ran-
dom field priors are common among those adopted in the disease 
mapping literature24–26. Note S1 provides a brief introduction 
to Markov processes and Markov random field models which, 
together with references given in the Methods section, serves as an 
entry point to the literature. The analyses outlined in this paper were 
performed using a so-called conditional autoregressive (CAR) 
form of Markov random field prior, as explained in Note S1.
Given a Bayesian hierarchical random effects model, some pro-
cedure is required for computing the posterior probability distri-
bution. This invariably involves complicated high-dimensional 
integrals that have no analytical solution. MCMC is often adopted 
as a method that circumvents the analytical intractability of this 
kind of problem23,27,28. The Gibbs sampler is among the most widely 
used MCMC algorithms; it is based on an iterative sampling of a 
set of conditional distributions. The CAR prior referred to in the 
preceding paragraph (a conditional distribution by definition), thus 
fits naturally into the Gibbs sampler algorithm, and the resulting 
computational efficiency is among the appealing features of adopt-
ing this prior when performing a Bayesian spatial analysis using 
the Gibbs sampler. Computer software for performing Bayesian 
spatial data analyses is readily available, including Gibbs sampler 
implementations. The MCMC analyses outlined in this paper were 
performed using WinBUGS/GeoBUGS29,30.
In summary, the purpose of the present study was to develop a 
model for tumour ADC spatial heterogeneity. This was motivated 
by current biomedical research indicating that tumour hetero-
geneity has important implications in the search for improved 
cancer treatment strategies and for the investigation of tumour 
pathophysiology1–3. We have adopted a spatial random effects 
modelling approach to characterising heterogeneity, implemented 
using MCMC. Despite the merits of performing an MCMC anal-
ysis, the method is not infallible. Reliable statistics depend on 
achieving convergence to a stationary distribution. Convergence 
assessment is, therefore, an essential part of any MCMC analysis. 
In order to guard against misleading heterogeneity measures, we 
have paid reasonable attention to the convergence issue, in addi-
tion to addressing the question of model adequacy. The latter was 
achieved by using posterior predictive simulation to examine key 
features of the spatial statistical modelling results, as described in 
the Methods section.
Methods
Patient and imaging details
The data used in this study are the same as those used in a previ-
ous study22 for which ethical approval was granted by the National 
Research Ethics Service Committee London – Bloomsbury. 
Therefore, no additional approval was required. Patient details and 
related information are given in 22. The subset of patients selected 
for the present work were imaged using a Siemens Magnetom 
Symphony scanner, capable of generating magnetic field gradients 
of amplitude up to 30 mT m–1. DWI data were acquired using a 
diffusion-sensitized single-shot echo planar imaging sequence 
(acquisition matrix 128 × 128, image matrix 256 × 256, field-of-
view 230 × 230 mm, twenty 5mm slices separated by 2.5mm, TR 
3600 ms, TE 107 ms). In addition to a single b0 image, 6 diffusion- 
weighted images were acquired with b-values 500 and 1000 s mm–2 
for each of 3 orthogonal directions. The total imaging/sequence 
time was 56s.
Image data analysis
The data were not formally blinded because the investigation does 
not take the form of a clinical trial. Instead, the purpose of the 
study was to develop a statistical model, with parameter estima-
tion as the objective, focussing on tumour heterogeneity measures. 
Thus the goal is parameter estimation as distinct from hypothesis 
testing. That said, the model development and data analyses were 
performed by MDK, using image signal intensity data provided in 
NIFTI format, with all sources of identification removed. The FSL 
utility tools (Version 4.1.5) fslview, fslslice and fsl2ascii (http://
fsl.fmrib.ox.ac.uk/fsl/fslwiki/Fslutils) were used to identify the 
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location of each tumour, and to extract the DWI signal intensity 
data from the tumour region, with conversion to ASCII format.
Region-of-interest selection was based on an inspection of ADC 
maps. A core ROI of 15-by-15 voxels was placed at a position 
well removed from the tumour boundary, as shown for one case in 
Figure 1. Tumour boundary ROIs were selected in that portion of 
the tissue where the boundary is easily identified due to the presence 
of adjacent oedematous voxels. A subject-specific ADC threshold 
was chosen and used to define tumour versus extra-tumour voxels. 
These thresholds were based on an inspection of the ADC values 
in oedematous voxels, together with a visual examination of the 
segmentation obtained with alternative values. ADC profile plots 
were used to select the boundary ROI width, as judged by the 
number of voxels over which the boundary distance effect vanishes, 
and the ADC becomes indistinguishable from typical core values. 
Boundary distance was equated to the minimum of the row and 
column distances. (No marked differences occurred when the 
analyses were performed using minimum Euclidean distances.) 
Figure 1 includes a magnified portion of the ADC image to show 
the boundary ROI in greater detail. It also shows part of the cor-
responding array of ADC values. In this case a threshold of 117 
was used to distinguish tumour versus oedematous voxels. This 
study is of an exploratory nature, and tumour boundary identifica-
tion and ROI selection are among the issues that require refinement, 
given the fact that the tumour boundary is never well defined in 
its entirely. We return to the ROI selection and automation 
problem in the Discussion.
Statistical model
The main purpose of the modelling study outlined in this paper is 
to determine whether DWI data obtained from PNET (primitive 
neuroectodermal tumour) cases provide statistical evidence to sup-
port the proposition that water diffusivity in the boundary region of 
some tumours exhibits a dependence on distance from the bound-
ary, in excess of an underlying 2D spatial heterogeneity in diffu-
sion. Tumour ADC dependence on boundary-distance has been 
reported in previous publications, and the principal objective is to 
determine whether this effect can be demonstrated given a model 
that includes additional 2D spatial variation. The distinction is 
between a monotonic change in diffusion in a direction approxi-
mately normal to the boundary, compared with an underlying 
and general 2D spatial dependence, with no distinct orientation 
relative to the tumour boundary. Specifically, an inverse tumour 
boundary-distance term is included in the diffusion model, together 
with additional random effect diffusion terms to capture the under-
lying 2D spatial heterogeneity (spatial correlation structure). 
Separate random effect terms are assigned to each of the three 
(read, phase and slice) diffusion coefficients. Interest focusses on 
the magnitude and statistical significance of the inverse-distance 
coefficient, in order to determine whether a formal spatial model 
provides robust evidence for a boundary effect. The statistical 
model allows the boundary voxels to differ from core voxels in their 
spatial correlation/heterogeneity, thus facilitating a comparison of 
the two regions. Furthermore, the model deals with the complica-
tion that arises from non-monoexponential signal-intensity depend-
ence on gradient amplitude, combined with an additional limitation 
arising from our using existing DWI data acquired with a stand-
ard clinical image acquisition protocol. The main limitation of the 
clinical data is a lack of replication. Thus each DWI dataset consists 
of 7 images only, namely, a single b0 image plus single acquisi-
tions with gradient sensitisation in the x, y and z directions and 
b-values of 500 and 1000 s mm–2. The lack of b0 data replication 
coupled with the non-monoexponential decay is the main challenge 
Figure 1. Core and boundary ROIs. The left panel shows an ADC image with the core ROI (square region) and boundary ROI (irregular 
region) superimposed. The boundary ROI is shown with increased magnification in the upper right panel. The array of ADC values given in 
the lower right panel are taken from the subregion indicated by the white box. The lines superimposed on the ADC array correspond to the 
ROI boundary.
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because a standard analysis cannot yield estimates of the true b0 
signal intensities separated from the accompanying noise. An 
additional limitation of the clinical data is the restriction to two 
non-zero b-value observations in each direction, again with no 
replication. The required diffusion parameter estimates can be 
obtained, however, under the spatial model outlined below, despite 
the departure from exponential dependence on magnetic field 
gradient amplitude and lack of replication. In essence the model 
assumes an exponential dependence in a b-value range that 
includes the b500 to b1000 observations, and captures the departure of 
the b0 signal intensity from the exponential curve using an offset 
parameter (δi in equation 3). The latter is incorporated in the form 
of a random effect term, and it is among those that are assigned 
a spatial CAR prior distribution (the CAR prior is outlined in 
Note S1). The essential features of the measurement model are 
illustrated in Figure 2. To re-iterate, an offset term captures the 
low b-value signal decay and yields a b0 signal intensity esti-
mate, separated from the noise contribution, despite the lack of 
b0 replication. The b0 signal intensity estimates are subject to two 
constraints, namely the underlying spatial distribution referred to 
above, together with a measurement error distribution with variance 
equal to the error variance of the finite b-value observations. This 
approach is preferable to treating the b0 observations as error free. 
The resulting voxel-specific signal intensity and diffusion param-
eter estimates were used to calculate a summary parameter, ADC0.5 
(given the symbol d¯´ in the following equations), based on the 
half-maximum-intensity b-value estimates, thus circumventing the 
non-monoexponential decay problem. The model details are as 
follows.
The measurement model takes the form 
                  ( )( , ) ( ( , ),1/ ) 1i j j i j j ry b k N b kµ τ∼                       (1)
                         μi(bj, kj) = Si exp(−bjdikj), j = 1, 2,…, 6                 (2)
                       μi(0, k ↑) = Si + δi                                                                                       (3)
Figure 2. A schematic showing the b-value dependence in signal intensity in relation to key terms in the statistical model. Signal 
attenuation from a b-value of 380 s mm–2 up to 1000 s mm–2, and beyond, is assumed to be exponential, with a voxel-specific diffusivity 
characterised by ADCs (slow diffusion ADC component). The model allows for a departure from mono-exponential behaviour, which is 
assumed to occur below a b-value of 380 s mm–2. (The need to assume that the mono-exponential behaviour extends down to 380 s mm–2 
arises because some of the 0.5bˆ  estimates (definition given below), which are used to calculate the ADC0.5 estimates, are less than 
500 s mm–2, the lowest falling at approximately 380 s mm–2. In contrast, the mono-exponential assumption underlying the ADCs calculations 
is restricted to the b-value range 500 s mm–2 to 1000 s mm–2.) An offset term, δ, captures the additional signal attenuation that occurs over the 
b-value range 0 to 380 s mm–2, thus accounting for the expected departure from mono-exponential behaviour at low b-value. δ is the 
difference between the true b0 signal intensity and the intercept, S, given by the mono-exponential expression for signal intensity. The dashed 
curve shows this exponential behaviour extrapolated to zero b-value. As outlined in the Statistical model subsection of the Methods section, 
ADC0.5 is calculated using ( )0.5ˆ (2 / 0, ) / ,b log S k d= µ ↑  where 0.5ˆb  is the b-value at the half-maximum signal intensity, noting that the subscript 
labels used in the main text (indicating that each of these parameters is voxel specific) have been dropped for the sake of simplicity. Similarly, 
the associated random effect terms are not included in the schematic.
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where yi(.) is a signal intensity observation in the ith voxel, the 
symbol ~ indicates ‘distributed as’ and N(μi (.), 1/τr) is the nor-
mal distribution with mean μi(.) and residual variance = 1/τr (i.e., 
τ
r
 is the precision of the measurements). The subscript labels k1 = 
k4 = x, k2 = k5 = y, k3 = k6 = z refer to the magnetic field gradient 
directions, b1 = b2 = b3 = 500 and b4 = b5 = b6 = 1000 are the DWI 
b-values (s mm–2), while k ↑ indicates that k is not defined when 
b = 0. Si is the b0 intercept in the monoexponential signal intensity 
expression for the ith voxel, dikj are voxel- and direction-specific 
apparent diffusion coefficients and δi a voxel-specific term that 
captures the departure from monoexponential dependence at low 
b-values. The following equations complete the statistical model, 
where the subscripts b and c are used to indicate boundary and 
core voxels, respectively. (Note that several model parameters are 
completely defined within the hierarchical set of equations and do 
not require further definition.) 
                    µ θ= + =1, 1,2,...,i s i TS i N                                         (4)
                    
δδ µ θ= + =2 , 1,2,...,i i ci N                                         (5)
                    
δδ µ θ α= + + = +2 , 1,...,i i i c Tl i N N                         (6)
                   
µ θ= + = =, 1,2,...., ; , ,
kcik d ik c
d i N k x y z
                     (7)
                   µ θ β= + + = + =, 1,..., ; , ,
kbik d ik i c T
d l i N N k x y z       (8)
where N
c
 and NT are the number of core voxels and total number 
of voxels, respectively, μ
s
, μδ, μdkc and μdkb are intercept terms, θip, 
p = 1,2, are spatial random effects and l is the boundary distance. 
(In equation 7 and equation 8, the acquisition label, j, that appears 
as a subscript in equation 2 has been dropped.) The coefficient α 
captures the magnitude of the boundary-distance dependence in 
the departure from monoexponential behaviour and β captures the 
boundary-distance dependence in the diffusion coefficients. The 
random coefficients θik in equation 7 and equation 8 were assigned 
ROI-specific prior distributions to allow the boundary and central 
regions to differ in their level of spatial correlation, noting that in 
the boundary region this 2D spatial heterogeneity is supplementary 
to the inverse boundary-distance effect on diffusion. Each of the 
eight sets of random effect terms was assigned a spatial CAR (con-
ditional autoregressive) prior as follows: 
                θθ θ ω = =∼ …
2( , / ), 1, , ; 1,2
pip ip i T
N r i N p                     (9)
                θθ θ ω = =∼ …
2( , / ), 1, , ; , ,
kcik ik i c
N r i N k x y z                 (10)
                θ
θ θ ω = + =∼ …2( , / ), 1, , ; , ,
kbik ik i c T
N r i N N k x y z
       
(11)
where θ θω ω2 2,p kc  and θω
2
kb
 are conditional variance parameters, ri is 
the number of voxels adjacent to the ith voxel, and θ θ,ip ik  are con-
ditional means given by 
                     θ θ
∈∂
= = =∑ …/ , 1, , ; 1,2
i
ip mp i T
m
r i N p                           (12)
                    
θ θ
∈∂
= = =∑ …/ , 1, , ; , ,
i
ik mk i T
m
r i N k x y z
                       
(13)
in which ∂i is the set of voxel labels belonging to the neighbours 
of the ith voxel. The CAR priors were implemented using the 
GeoBUGS car.normal function (see below) with dispersion 
specified as precision parameters, i.e., reciprocal variance, each of 
which was assigned a Gamma(0.5, 0.0005) distribution at the next 
level in the prior hierarchical structure. The measurement precision, 
τ
r
, and intercept terms were assigned an uninformative gamma prior 
and flat prior distributions, respectively. An important feature of 
equation 8 is the contribution provided by the inverse distance term. 
This contrasts with the linear dependence on distance adopted by 
some analysts. A linear distance dependence is a counter-intuitive 
model for decay, given a non-negative diffusion coefficient. Thus, 
an inverse distance dependence was adopted because it approaches 
zero asymptotically. In particular, it cannot become negative when 
β is positive.
In summary, the model includes a spatial random effects term (θi1) 
to cater for between-voxel variation in the b0 intercept of the slow-
diffusion component (i.e., Si in equation 2), specified as having a 
conditional variance common to both boundary and core voxels, a 
spatial random effect term (θi2) to allow for between-voxel varia-
tion in the fast-diffusion component, i.e., the departure from mono-
exponential decay, again with a conditional variance common to 
the two regions, and spatial random-effect contributions (θik, k = 
x, y, z) to the magnetic field gradient direction-specific diffusion 
coefficients, with separate conditional variances assigned to the 
core and boundary and to each direction. A diffusion summary 
parameter (d¯′) was adopted to circumvent the complication that 
arises due to non-exponential b-value dependence. This is based 
on the assumption that the direction-specific mono-exponential 
expression for signal attenuation given in equation 2 applies over 
the range b380 to b2000. (With the exception of a few outliers with 
larger values, the voxel-specific b^0.5i estimates, referred to below, 
lie within this b-value range. It might be noted that a proportion 
of these estimates lie outside the b500 and b1000 range, which is not 
ideal. This problem is a reflection of our using retrospective clini-
cal data obtained with an imaging sequence that was designed for 
routine DWI, as opposed to detailed statistical modelling.) Accord-
ingly, a voxel-specific half-maximum signal-intensity b-value was 
calculated using 0.5ˆ (2 / (0, )) / ,i i i ib log S k dµ= ↑  where d¯i = (dix + diy 
+ diz)/3 is the mean diffusivity (the subscript i is the voxel label, not 
to be confused with the convention where it is used to indicate an 
isotropic parameter). This is used, in turn, to calculate the summary 
parameter 0.5ˆ(2) / .iid log b′=  For the sake of conciseness and read-
ability the voxel subscript is dropped in the Results and Discussion 
sections, and the abbreviations ADCs, ADC0.5 and μ0 are used for 
d¯i, d¯i′ and μi(0, k ↑), respectively, i.e., the slow-diffusion ADC 
component, the ADC based on an estimate of the half-maximum 
signal intensity, and the b0 signal intensity estimate. A schematic 
showing the relationship between the key model parameters and 
the b-value dependence in signal intensity is shown in Figure 2.
Derived parameters
The summary parameters ADCs and ADC0.5 were calculated using 
the definitions given above. The various range statistics were 
generated by evaluating the relevant minimum and maximum 
voxel-specific values at each MCMC iteration. Thus the resulting 
statistics include all sources of variation/error, including uncertainty 
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in the identity of the voxels responsible for the extreme values. 
The boundary-region 2D heterogeneity ADCs statistics listed in 
Table 2 were derived from the average of the three magnetic field 
gradient-specific diffusion coefficients, as obtained for each voxel 
with the boundary effect (β/li) removed (i.e., based on dik = μdkb 
+ θik, i = Nc + 1, . . ., NT; k = x, y, z; compare with equation 8). 
The third data column in Table 2 lists the boundary distance-effect 
(β/li, i = Nc + 1, . . ., NT) ranges, as given by the difference between 
the maximum and minimum voxel-specific values.
Implementation
Bayesian spatial modelling and its implementation using MCMC 
is well documented (see, for example, 24–26,31). We have previ-
ously demonstrated the application of this modelling approach to 
the crossing-fibre problem that arises in diffusion tensor imaging32 
and the sparse data problem that often arises in MR perfusion and 
diffusion image analyses33,34. Gibbs sampling was performed using 
the WinBUGS/GeoBUGS package (Version 1.4.3)29,30,35,36, which 
was downloaded from http://www.mrc-bsu.cam.ac.uk/bugs. Three 
parallel chains were generated for each of the five analyses (5 cases 
examined in total), each chain consisting of 5000 samples after 
thinning. (Thinning is the name given to the common practice 
whereby a specified proportion of the MCMC output is discarded, 
the remaining samples being stored for subsequent processing. 
It has been discussed by a number of analysts, including Carlin 
and Louis (2009) (Section 3.4.5 in 28). The reason for thinning 
the MCMC output is to produce a chain with reduced sample 
autocorrelation. The aim is to reduce both the storage and post- 
simulation CPU demands of an analysis without suffering much 
loss in precision. A thinning factor of 40 was used in the major-
ity of the simulations, excepting the posterior predictive analyses, 
which were performed using a thinning factor of 10. Thus, 1 in 40 
(or 1 in 10) samples was stored and used in subsequent calcula-
tions). The first of each set of three chains was started at an arbitrary 
position in parameter space, while the other two were started at 
over-dispersed positions. A burn-in set of samples was acquired 
prior to storing each chain of 5000 samples. The burn-in samples 
were discarded.
MCMC convergence
An informal assessment of convergence was performed by inspect-
ing selected overlaid trace plots for visual signs of convergence 
failure. (MCMC convergence analysis is a topic that has been 
discussed by many analysts, as summarised in several textbooks, 
(Gelman et al23, and Carlin and Louis28, for example) and discus-
sion papers37,38. Our approach is based partly on their recommen-
dations.) This visual assessment was followed by a semi-formal 
analysis (see 39 for a review of the methods) which was performed 
using three convergence test procedures, namely the Gelman-Rubin 
shrink factor diagnostic and associated shrink factor plots (which 
is based on an ANOVA-like assessment of the between-chain 
and within-chain variances), the Geweke Z-score diagnostic and 
Z-score plots (based on spectral density variance estimation and 
a Z-score comparison of chain segments), and the Raftery-Lewis 
diagnostic procedure (which provides a variety of data, including 
an estimate of the number of iterations required to obtain a given 
quantile to some specified accuracy, taking into account the cor-
relation between samples). Particular attention was paid to the 
accuracy obtained for the key measures of spatial variation. These 
convergence analyses were performed using the R CODA (Conver-
gence Diagnosis and Output Analysis) package40 (R version 2.15.2, 
CODA version 0.16-1).
Model assessment and posterior predictive simulation
Model assessment was undertaken using posterior predictive sim-
ulation (41–43; Chapter 6 in 23, provides a useful introduction.) 
This is an established procedure which can be used to calculate 
so-called posterior predictive p-values or Bayesian p-values, which 
serve to determine whether some aspect of the data is unexpected 
under the model, indicating potential model inadequacy. The objec-
tive is to adopt tests that probe the capacity of the model to capture 
features in the data that are key to the scientific question underly-
ing the research (see, for example, page 172 in 23). In the present 
study the resulting Bayesian p-values are used as probabilistic 
measures of the extent to which the observed signal intensities are 
more extreme than the posterior predictive data (yrep). In short, the 
p-values provide a measure of discrepancy. Following Gelman 
et al.23, page 162, and noting that in the present analysis the test 
quantity depends only on the data, 
                                Pr( ( , ) ( ) | )repBp T y T y yθ= ≥                    (14)
taken jointly over the posterior predictive distribution of yrep and the 
posterior distribution of the model parameters (θ). An estimate of 
pB is given by the proportion of L simulations satisfying 
  
θ ≥ = …( )( , ) ( ), 1, , .rep l lT y T y l L
                   (15)
In those instances where this yields a p-value greater than 0.5, 
the sign of the test is reversed. Thus improbable test results are 
indicated by Bayesian p-values near zero.
The preceding mathematical expressions differ from those given 
in 23, the latter using discrepancy measures that depend on 
unknown parameters, in addition to the data. In the present study, 
posterior predictive tests were all performed using signal intensity 
in isolation as a measure of discrepancy. (Thus T(y, θl), as given on 
page 163 of 23, becomes T(yi) = yi, where i is the voxel label.) The 
rationale behind focusing on discrepancies between the observed 
signal intensities and replicate data generated under the model was 
as a simple procedure to detect potential outliers, and to deter-
mine whether these are associated with extreme ADC estimates, 
leading to spurious heterogeneity measures, noting that tumour 
heterogeneity is the focus of the study.
Results
The Results section of this paper is organised as follows. The first 
subsection reports the main findings of the tumour spatial heteroge-
neity analysis, which compares the level of heterogeneity observed 
in the core and boundary region of five tumours. This is followed 
by two subsidiary sections, the first of which examines the bound-
ary distance effect in greater detail, followed by a subsection deal-
ing with potential anisotropic behaviour in the observed spatial 
heterogeneity. The final subsection provides a brief summary of the 
MCMC convergence and simulation accuracy analyses, together 
with a summary of the posterior predictive simulation results.
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Tumour heterogeneity
The main motivation for the ADC analysis outlined in this paper 
is the MRI literature suggesting that the ADC in the boundary 
region of some tumours exhibits a voxel-specific dependence on 
distance from the tumour boundary14,17,22. The aim was to deter-
mine whether an analysis based on a formal spatial model provides 
supporting evidence for a boundary effect after adjusting for an 
underlying random 2D spatial heterogeneity. In this context the 
statistical model accommodates several parameters of potential 
interest. These include a term, specific to the boundary ROI, which 
assumes an inverse dependence of the anisotropic diffusion coef-
ficients on distance from the tumour boundary. This effect is super-
imposed on an underlying random 2D spatial heterogeneity that is 
assumed to exist in both the boundary and core regions. The lat-
ter general heterogeneity is incorporated in the form of so-called 
spatial random effect terms. The magnitude of the resulting 2D 
spatial heterogeneity is allowed to differ between the two regions. 
Interest focusses on potential subject-specific differences in hetero-
geneity between the boundary and core regions, together with the 
magnitude of the boundary distance effect. A note of explanation 
might assist readers unfamiliar with the Bayesian terminology used 
in this paper. Each of the model parameters is estimated with error. 
This uncertainty is captured by the posterior probability distribu-
tion. The posterior median provides a point estimate of the true 
parameter value, while the tail quantiles give an indication of the 
uncertainty in the estimate. 95% posterior intervals are given for 
every parameter estimate, including the various range parameters 
which are used as measures of spatial heterogeneity. In the latter 
case, the 95% posterior intervals provide a measure of the range of 
uncertainty in the ADC range estimates.
Table 1 lists the minimum and maximum voxel-specific ADCs 
estimates, as obtained for the core and boundary regions in five 
subjects, together with the corresponding range statistics. The main 
result that emerges from this table is that heterogeneity in the core 
is not consistently less than that observed in the boundary region, 
despite the additional boundary distance-effect contribution to the 
latter. Thus, although heterogeneity in the boundary region ADCs is 
substantially larger than that observed in the core in 3 of the 5 cases, 
in one of the remaining cases (Subject 2) the core region exhibits a 
greater level of heterogeneity.
Table 2 provides estimates of the magnitude of the random 2D spa-
tial heterogeneity contribution to the boundary-region variation in 
diffusivity, as captured by the spatial random effects, together with 
the variation attributable to the deterministic boundary-distance 
effect, which operates close to the boundary, and the magnitude 
of the random 2D spatial heterogeneity in the core. Again, these 
are expressed in the form of ADCs range statistics, as given by the 
difference between the minimum and maximum voxel-specific 
ADCs values. The core-region range statistics are included for 
completeness, although these are identical to those given in 
Table 1. No consistent pattern emerges from a comparison of the 
boundary and core spatial random effect ranges (ie the random 
2D heterogeneity effect). In particular, there is no indication of a 
consistently greater level of heterogeneity in one region com-
pared with the other. A comparison of the boundary distance- 
effect ranges with the corresponding boundary random 2D het-
erogeneity ranges suggests that both are important sources of 
spatial variation, although the 2D heterogeneity component 
dominates in two of the five cases (Subjects 4 and 5).
Having examined the relative magnitude of the ADCs het-
erogeneity in the boundary-region with that in the core, Table 3 
focusses on ADC0.5. ADC0.5 (denoted d¯′ in the Methods section) is 
a diffusion summary parameter that captures the signal intensity 
Table 1. Subject-specific tumour ADCs parameter estimates in the core and boundary region.
Subject
Boundary region ADCs*  
10−3 mm2 s−1
Core region ADCs*  
10−3 mm2 s−1 
Minimum Maximum Range Minimum Maximum Range
1 0.33(0.29, 0.37)
0.73
(0.68, 0.80)
0.40
(0.34, 0.48)
0.47
(0.45, 0.50)
0.61
(0.59, 0.63)
0.13
(0.10, 0.17)
2 0.57(0.53, 0.61)
0.87
(0.84, 0.91)
0.30
(0.25, 0.36)
0.46
(0.40, 0.50)
0.93
(0.89, 0.97)
0.47
(0.42, 0.54)
3 0.47(0.44, 0.50)
0.78
(0.75, 0.82)
0.31
(0.27, 0.36)
0.49
(0.46, 0.52)
0.80
(0.76, 0.86)
0.31
(0.26, 0.37)
4 0.40(0.35, 0.43)
0.97
(0.92, 1.05)
0.58
(0.51, 0.66)
0.43
(0.41, 0.45)
0.50
(0.49, 0.52)
0.068
(0.047, 0.095)
5 0.38(0.35, 0.40)
0.78
(0.76, 0.81)
0.41
(0.37, 0.45)
0.34
(0.32, 0.36)
0.46
(0.44, 0.49)
0.12
(0.09, 0.15)
*The median of the posterior distribution obtained for each of the specified ADCs parameters is listed, together 
with the 0.025 and 0.975 quantiles, which are given in brackets.
Core and boundary-region minimum and maximum voxel-specific ADCs estimates are listed, together with the 
corresponding ranges (difference between the maximum and minimum of the voxel-specific estimates). The ADCs 
range estimates, which are used as measures of ADCs dispersion, are derived from the raw MCMC sample, as 
opposed to subtracting the listed minimum and maximum values, hence the apparent discrepancy between some 
of the extreme-value and corresponding range statistics.
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Table 2. 2D spatial heterogeneity and boundary-distance effect ADCs range statistics.
Subject
2D heterogeneity ADCs range* 
10−3 mm2 s−1 Boundary distance-effect ADCs range* 
10−3 mm2 s−1 
Core Boundary
1 0.13
(0.10, 0.17)
0.24
(0.18, 0.31)
0.19
(0.15, 0.22)
2 0.47
(0.42, 0.54)
0.16
(0.13, 0.20)
0.14
(0.10, 0.19)
3 0.31
(0.26, 0.37)
0.17
(0.13, 0.21)
0.15
(0.13, 0.17)
4 0.068
(0.047, 0.095)
0.37
(0.31, 0.44)
0.24
(0.20, 0.28)
5 0.12
(0.09, 0.15)
0.32
(0.29, 0.37)
0.16
(0.13, 0.18)
*The median of the posterior distribution obtained for each ADCs range estimate (10−3 mm2 s−1) is listed, 
together with the 0.025 and 0.975 quantiles, which are given in brackets.
Range statistics are used as measures of ADCs dispersion in order to determine the relative contribution 
of the underlying sources of spatial variation. ADCs dispersion in the boundary region is composed of a 
random 2D spatial heterogeneity contribution and a deterministic boundary-distance effect which operates 
close to the tumour boundary. In contrast, dispersion in the core is restricted to a random 2D heterogeneity 
effect, which is permitted to differ in magnitude to the 2D spatial variation observed within the boundary 
region. Core region ADCs ranges are listed in the first data column, as determined by the difference 
between the maximum and minimum voxel-specific ADCs values within the selected region. ADCs range 
estimates attributable to the boundary-region 2D spatial heterogeneity component are listed in the second 
data column. The third data column lists the contribution of the boundary-distance effect, again expressed 
as an ADCs range equal to the difference between the voxel-specific maximum and minimum values within 
the boundary region.
Table 3. Subject-specific tumour ADC0.5 parameter estimates in the core and boundary 
region.
Subject
Boundary region ADC0.5* 
 10−3 mm2 s−1 
Core region ADC0.5*  
10−3 mm2 s−1 
Minimum Maximum Range Minimum Maximum Range
1 0.44(0.39, 0.48)
1.15
(1.06, 1.27)
0.71
(0.61, 0.84)
0.58
(0.54, 0.60)
0.98
(0.93, 1.05)
0.41
(0.35, 0.48)
2 0.61(0.56, 0.65)
1.34
(1.25, 1.47)
0.73
(0.63, 0.87)
0.58
(0.52, 0.62)
1.39
(1.32, 1.49)
0.81
(0.73, 0.93)
3 0.48(0.45, 0.51)
1.12
(1.06, 1.19)
0.64
(0.58, 0.72)
0.53
(0.50, 0.55)
1.62
(1.49, 1.82)
1.09
(0.96, 1.29)
4 0.40(0.36, 0.44)
1.41
(1.35, 1.50)
1.01
(0.94, 1.11)
0.48
(0.46, 0.50)
0.63
(0.61, 0.66)
0.15
(0.12, 0.18)
5 0.39(0.36, 0.41)
0.90
(0.88, 0.93)
0.52
(0.48, 0.56)
0.36
(0.34, 0.37)
0.49
(0.47, 0.51)
0.14
(0.11, 0.16)
*The median of the posterior distribution generated for the specified ADC0.5 parameter is listed, together 
with the 0.025 and 0.975 quantiles, which are given in brackets.
The core and boundary-region minimum and maximum voxel-specific posterior ADC0.5 (denoted ′d  in the 
Methods section) estimates are given, together with the corresponding ranges. ADC0.5 is derived from 
the half-maximum signal intensity point on the mono-exponential decay curve as outlined in the Methods 
section. Spatial variation in the boundary region includes contributions from a random 2D heterogeneity 
in ADCs (captured by the diffusion coefficient random effect terms), a deterministic boundary-distance 
effect on diffusion and a boundary distance contribution to heterogeneity in the b0 signal intensity. The 
range statistics are derived from the raw MCMC sample, as opposed to subtracting the listed maximum 
and minimum values, hence the apparent discrepancy between some of the extreme value estimates and 
corresponding range statistics.
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Table 4. Subject-specific boundary-distance regression coefficients.
Regression 
coefficient Subject 1 Subject 2 Subject 3 Subject 4 Subject 5
β* 0.25 (0.20, 0.29) 0.19 (0.14, 0.25) 0.19 (0.16, 0.22) 0.29 (0.24, 0.34) 0.19 (0.16, 0.22)
α** 19.5 (5.4, 33.0) 12.0 (-8.5, 32.8) 39.1 (23.9, 54.3) 52.3 (42.6, 61.6) 14.5 (8.1, 21.5)
*10−3 mm2 s−1 × (voxel size); **image intensity units × (voxel size). (Note the inverse distance dependencies in equation 6 and 
equation 8.) 
Regression coefficient posterior median estimates are listed together with the 0.025 and 0.975 posterior quantiles, which 
are given in brackets. β is the coefficient in the term that captures the boundary inverse-distance dependence of each of 
the 3 (phase, read and slice) voxel-specific diffusion coefficients, while α is the coefficient in a term that allows for boundary 
inverse-distance dependence in the b0 signal intensities. The regression model details are given in the Methods section.
departure from an exponential dependence on b-value as it 
approaches zero, in addition to the slow diffusion component. It 
is based on an estimate of the b-value at the half-maximum sig-
nal intensity. (In contrast, ADCs is based on the monoexponen-
tial expression for diffusion (slow diffusion component) that is 
assumed to apply at b-values between 500 s mm–2 and 1000 s mm–2. 
The ADC0.5 calculation supposes that the departure from mono- 
exponential dependence occurs below 380 s mm–2. Details of the 
ADCs and ADC0.5 estimation method are given in the Methods 
section.) Again, no consistent pattern emerges, noting that in one 
of the five subjects (Subject 3) the core region appears markedly 
more heterogeneous than the boundary region.
Diffusion dependence on distance from the boundary
The results given in the preceding section indicate that the boundary- 
distance effect on diffusion (captured by the term β/l in equation 8) 
makes an important contribution to the spatial heterogeneity in 
ADC that is observed in the vicinity of the tumour boundary. In 
this section the effect is examined in greater detail. In addition to 
diffusion-coefficient dependence on boundary distance, an inverse 
distance term has also been added to the expression for the b0 signal 
intensity in the boundary region (α/l in equation 6), although there 
is no prior reason for assuming that this term will be important. 
The regression-parameter posterior median estimates are given in 
Table 4, together with the corresponding posterior 0.025 and 0.975 
quantiles. With the exception of the posterior interval listed for 
α in Subject 2, the remaining 0.95 posterior intervals all exclude 
zero. This provides statistical evidence for the presence of a 
boundary distance effect on the slow diffusion component in all 
five cases, together with evidence for a boundary effect on the low 
b-value portion of the signal intensity curve (rapidly attenuated 
fast diffusion component) in 4 of the 5 cases.
A visual representation of the magnitude of the boundary effect 
is given in Figure 3. The upper row shows the voxel-specific median 
ADCs estimates plotted against distance from the boundary. The 
corresponding ADC0.5 plots are given in the lower row. Superim-
posed on each graph is a median curve showing the boundary- 
distance dependence in ADCs, as given by the β/l term in 
equation 8. These curves have an arbitrary intercept (because the 
expression for diffusion includes additional random effect and 
intercept terms) and are shown with an intercept chosen to give a 
mid point equal to the overall median. The scatter in ADCs values 
at a given distance is attributable to the diffusion coefficient spatial 
random effect terms and provides a visual indication of the mag-
nitude of the underlying 2D spatial heterogeneity in the diffusion 
coefficients (slow diffusion component). Consistent with the results 
given in the preceding section, and the statistics listed in Table 4, 
these plots show that the boundary distance effect makes a marked 
contribution to the spatial dependence in ADCs and that it is 
not completely dominated by the 2D spatial heterogeneity captured 
by the diffusion coefficient random effect terms. The relationship 
between ADC0.5 and β/l is less obvious indicating the importance 
of other sources of spatial variation. Scatter in the ADC0.5 values 
at a given distance from the boundary is accounted for by the 
entire set of random effect terms that are incorporated into the 
model, including those that capture the 2D spatial heterogeneity in 
the fast diffusion component.
A comparison of the data shown in Figure 3 with those given in 
Table 3 reveals small differences between the two, particularly 
with respect to the ADC0.5 maxima, some of those listed in the 
table being noticeably larger than shown in the figure. In fact, all 
of the minimum and maximum ADC0.5 values listed in the table 
are more extreme than shown in the figure, although in some cases 
the difference is negligible. Focusing on the estimated maxima, the 
differences arise because the figure shows the median voxel-specific 
ADC0.5 estimates (and quantiles) while the table lists the median 
(with 95% posterior interval) of the maximum ADC0.5 estimates. 
The latter are not voxel-specific, but take account of uncertainty in 
the voxel associated with the maximum values. The median of the 
maximum ADC0.5 estimates tend to be larger than the maximum 
of the median voxel-specific estimates, which is expected. Simi-
lar differences arise in the ADCs results, but are less obvious. The 
estimates given in the tables provide the required characterisation 
of tumour heterogeneity. On the other hand, Figure 3 provides a 
visual impression of the heterogeneity among the voxel- 
specific ADC estimates, and the dependence on boundary distance. 
Restated, the maximum of the voxel-specific median ADC val-
ues does not equal the median of the maximum ADC estimates, 
within the selected region. It is the latter that are used to derive 
the ADC range statistics, because these capture uncertainty in the 
identity of the voxels responsible for the extreme values. The 
capacity to account for all sources of variation/error is among the 
advantages of the MCMC modelling approach adopted in this 
study. Among the limitations of a standard independent-voxels 
analysis (i.e., one based on independent voxel-specific estimates) is 
the lack of a formal mechanism for achieving this.
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Anisotropic heterogeneity
Finally we focus on the spatial-CAR precision parameters asso-
ciated with the three diffusion coefficients (phase, read and slice-
direction coefficients). They determine the magnitude of the 
dispersion in the diffusion coefficient spatial random effects, i.e., 
the underlying 2D spatial heterogeneity in ADCs. The boundary 
and core-region parameter estimates are listed in Table 5, after con-
version to standard deviations in order to show these on the same 
scale as the ADC estimates. Inspection of these data suggests the 
presence of considerable anisotropy in the level of diffusion het-
erogeneity, together with substantial between-subject differences. 
The values obtained for the core region in Subject 2 are particularly 
large, raising questions regarding the robustness of these statistics. 
We return to this issue in the Discussion.
It should be noted that the standard deviations reported in Table 5 
(square root of the inverse CAR precision parameter values) are not 
necessarily interpretable because they relate to local spatial struc-
ture as opposed to global variation over the entire ROI. Thus, in 
general, it is not meaningful to compare these conditional (local) 
dispersion parameters with standard measures of dispersion (see the 
Discussion for additional comments). As it happens, we do observe 
a relationship between each of the precision parameters and the 
corresponding region-specific diffusion-coefficient range of values. 
But this relationship is not guaranteed. We include Table 5 only 
because these data appear to suggest a considerable anisotropy in 
spatial structure.
MCMC convergence, simulation accuracy and posterior 
predictive simulation results
Convergence to a stationary distribution is a critical requirement 
in any statistical modelling analysis performed using MCMC. In 
the absence of convergence the resulting parameter estimates can 
be meaningless. In accordance with accepted procedure, an ini-
tial convergence assessment was performed using overlaid paral-
lel-chain trace plots. Given a set of chains started at overdispersed 
positions in parameter space, a failure to achieve a good coverage 
of the region of parameter space supported by the posterior distri-
bution is usually revealed by visual inspection. An additional semi- 
formal analysis was performed using the diagnostic tests listed in the 
Methods section. These tests were mainly restricted to the derived 
heterogeneity measures that are the focus of the study, includ-
ing α, β, the boundary- and core-region ADCs range variables, 
the boundary- and core-region ADC0.5 range variables, a derived 
parameter equal to the boundary spatial range with the β/l contribu-
tion removed, and the CAR precision parameters. In addition a few 
voxel-specific ADCs parameters were also examined. The result-
ing convergence test and simulation accuracy results are given in 
Note S2. In summary, there were no instances of compromise 
due to convergence failure. Regarding simulation accuracy, 
Raftery-Lewis calculations indicated that 5000 samples (after thin-
ning) were more than sufficient to provide the majority of nomi-
nal 95% credible intervals with a true coverage of between 94% 
and 96%, with probability 0.95. Where this was not achieved, the 
results indicate a true coverage of between 93% and 97%, with 
probability 0.95. We regard this level of accuracy to be satisfac-
tory, noting that the heterogeneity statistics provided in this paper 
are generated after combining the three individual chains generated 
for each case, thus providing an accuracy greater than given here 
for the individual chains.
As stated previously, convergence and simulation accuracy are not 
the only considerations. Clearly, model adequacy is central to the 
present analysis because an incapacity to capture the true DWI 
Figure 3. Diffusion dependence on distance from the tumour boundary. Voxel-specific ADCs estimates (top row) and ADC0.5 estimates 
(bottom row) in the boundary region plotted against distance from the boundary (distance given in units equal to the voxel size). ADCs is 
the slow ADC component, while ADC0.5 is derived from the half-maximum signal intensity estimate, and captures the signal attenuation that 
occurs at low b-value in addition to the slow component. The voxel-specific posterior medians are shown as dots while the posterior 0.025 and 
0.975 quantiles are shown as bars. Although the figure does not show which of the medians belongs to each pair of quantiles, it does serve 
to provide an indication of the between-voxel differences in ADC together with the uncertainty in the estimates. Each plot includes a curve 
showing the dependence given by the inverse-distance diffusion term (β /l in equation 8), each of which is plotted with an intercept chosen to 
give a mid point equal to the overall median ADC value.
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signal intensities is expected to give rise to meaningless measures 
of ADC heterogeneity. Posterior predictive simulation was used 
to examine the MCMC output for signs of model inadequacy. It 
provides a mechanism for distinguishing between observations 
that are unexpected under the model (i.e., indicative of model fail-
ure), and observations that are compatible with the model despite 
appearing extreme. Details are given in Note S2. Although there are 
instances where a very low Bayesian p-value was obtained, this is 
not unexpected given the relatively large number of signal-intensity 
observations involved in each image dataset. Paying attention to 
the Bayesian p-values obtained for those voxels that give rise to the 
extreme parameter values that determine each of the reported het-
erogeneity estimates (i.e., the various range statistics), there are no 
instances where the p-value falls below 0.01. The conclusion is that 
there are no instances where an extreme ADC estimate gives rise to 
a spurious measure of heterogeneity, i.e., where an inflated hetero-
geneity estimate arises due to a spurious signal intensity observa-
tion or due to model failure. Re-stated, the model appears adequate 
in terms of its capacity to capture the true underlying tumour ADC 
heterogeneity.
Discussion
Tumour ADC heterogeneity. A comparison of core and 
boundary regions
The focus of this study is a statistical modelling procedure for 
characterising intra-tumour heterogeneity. This was motivated by 
a well-established literature indicating that tumour heterogeneity 
has major implications for the development of improved treatment 
strategies and for the basic understanding of tumour development 
and pathophysiology. Among the important features of the approach 
that has been adopted is a single-stage analysis in which spatial 
heterogeneity is modelled simultaneously with signal intensity fit-
ting. This is achieved by using a Bayesian spatial random effects 
model, implemented using MCMC. Some might question the need 
to adopt a formal spatial model, as opposed to a standard independ-
ent voxels (i.e., voxel-by-voxel) analysis. A brief statement of the 
general advantages of random effects modelling over an independ-
ent-units analysis is given in the Section on Bayesian random effect 
models that is included in the Introduction. In particular, we refer to 
the improvement in parameter precision that arises due to so-called 
information borrowing. Among the main ingredients of the random 
effects treatment adopted in this study are the spatial distributional 
constraints imposed by the CAR priors. These introduce a degree 
of spatial smoothing, referred to as shrinkage in the random effects 
context. The resulting voxel-specific ADC estimates and range sta-
tistics will, in general, be less extreme than those obtained from an 
independent-voxels analysis. In particular, the various range esti-
mates are expected to be smaller than those obtained by subtracting 
the voxel-specific maximum and minimum ADC values obtained 
in an independent-voxels analysis. In that sense, the present 
Table 5. Standard deviations* derived from the CAR precision parameters.
Subject
Boundary region  
10−3 mm2 s−1 
Core region  
10−3 mm2 s−1
Diffusion encoding direction Diffusion encoding direction
phase read slice phase read slice
1 0.094 (0.064, 0.129)
0.029 
(0.014, 0.056)
0.166 
(0.130, 0.210)
0.042 
(0.025, 0.059)
0.052 
(0.040, 0.066)
0.072 
(0.059, 0.087)
2 0.028 (0.013, 0.056)
0.019 
(0.011, 0.037)
0.122 
(0.096, 0.155)
0.094 
(0.076, 0.115)
0.119 
(0.099, 0.142)
0.234 
(0.208, 0.263)
3 0.072 (0.059, 0.087)
0.070 
(0.056, 0.087)
0.082 
(0.068, 0.097)
0.094 
(0.081, 0.108)
0.097 
(0.085, 0.111)
0.096 
(0.084, 0.110)
4 0.095 (0.080, 0.113)
0.157 
(0.138, 0.179)
0.131 
(0.114, 0.151)
0.040 
(0.026, 0.053)
0.030 
(0.020, 0.041)
0.031 
(0.019, 0.043)
5 0.067 (0.056, 0.079)
0.086 
(0.075, 0.100)
0.090 
(0.077, 0.104)
0.064 
(0.054, 0.074)
0.046 
(0.037, 0.057)
0.051 
(0.041, 0.061)
*The posterior median estimate of each standard deviation is listed together with the 0.025 and 0.975 quantiles, which are given 
in brackets.
CAR precision parameter values are listed after conversion to standard deviations. These provide a measure of local spatial 
dispersion and are shown on the same scale as the ADCs estimates. Specifically, the CAR precision (inverse variance) 
parameters determine the magnitude of local dispersion in the spatial random effects, i.e., the level of 2D spatial heterogeneity 
in the gradient-specific diffusion coefficients. It should be noted that the CAR precision parameters are conditional (by 
definition), and that a direct comparison with the other measures of dispersion given in this paper is invalid. Restated, measures 
of local dispersion are not, in general, directly related to global variability.
Dataset 1. Diffusion-weighted MR signal intensity observations 
and voxel adjacency data
http://dx.doi.org/10.5256/f1000research.9355.d132816
Data are provided for each subject as separate ASCII data files. 
Parameter/variable definitions are given in the readme file.
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random effects model analysis yields robust/conservative measures 
of heterogeneity.
The tumour heterogeneity analysis yields a variety of spatial statis-
tics that are potentially useful from a clinical perspective. The main 
conclusions are that the previously reported relationship between 
diffusion and boundary proximity remains observable and achieves 
statistical significance (the 95% posterior intervals exclude zero) 
after adjusting for an underlying random 2D spatial heterogeneity 
in the diffusion model parameters. In addition, the results suggest 
that the tumour core and boundary regions are distinguishable in 
terms of the ADC spatial structure captured by the random effect 
terms, notwithstanding the additional deterministic boundary 
effect. A comparison of the magnitude of the deterministic bound-
ary distance-effect with the underlying random 2D boundary het-
erogeneity suggests that both are important sources of variation in 
the vicinity of the boundary. No consistent pattern emerges from a 
comparison of the boundary and core spatial heterogeneity. In par-
ticular, the level of heterogeneity in the core is not consistently less 
than that observed in the boundary region, despite the additional 
boundary distance-effect contribution to the latter.
A potentially interesting observation is that the diffusion coefficient 
CAR-prior precision parameters (these conditional parameters are 
measures of local heterogeneity) exhibit a significant degree of 
anisotropy, which suggests that combining the direction-specific 
diffusion coefficients to obtain ADC measures of heterogeneity 
is accompanied by a loss of information. But caution is required 
given the possibility of over-interpretation due to over-fitting the 
data which consists of only seven signal intensity observations per 
voxel. The present study suffers a deficiency that is not uncommon 
in the MRI field, namely existing imaging data acquired using a 
standard clinical imaging sequence were used in a retrospective 
modelling exercise. The DWI acquisition protocol was designed to 
produce clinical ADC maps sufficient for visual inspection. Data 
of this type are unlikely to be optimum from a modelling perspec-
tive. In the present context a lack of replication within each data-
set, especially the lack of b0 replication, is particularly problematic. 
Obviously, the restriction to two non-zero b-values is an additional 
and severe limitation, noting the need to cater for departure from 
mono-exponential behaviour. Given signal intensity data consisting 
of 7 observations per voxel (b0, b500x, b500y, b500z, b1000x, b1000y, b1000z) 
the calculations are barely tractable. Clearly, b0 data replication 
would provide a more robust estimate of the true b0 signal intensity, 
thus facilitating estimation of the magnitude of the departure from 
mono-exponential behaviour and the noise contribution to the b0 
signal intensity observation. Given the present data, this is achieved 
only through the combined constraints provided by the error dis-
tribution and the autoregressive spatial prior associated with the b0 
signal-intensity observation. The residual error variance would be 
estimated with improved precision given a reasonable amount of 
replication.
An additional compromise arises in relation to the ADC0.5 sta-
tistics, because these are based on an estimate of the b-value at 
half-maximum signal intensity which, for some voxels, lies below 
500 s mm–2. Clearly it would be preferable to acquire data using 
a protocol that gives a better coverage of the critical range of 
b-values, and with suitable replication. Scan time is, however, a lim-
iting factor in achieving this ideal. Furthermore, replication of the 
entire DWI dataset and/or the entire imaging session would allow 
a formal assessment of the robustness of the various heterogeneity 
measures, and the suggestion of anisotropy in the CAR precision 
parameters. Unfortunately, given the need to work in a standard 
clinical setting, comprehensive within-scan replication coupled 
with replicate scanning is not a realistic option. In the absence of 
replicate data, a question arises regarding the plausibility of some 
of the dispersion statistics reported in this paper, in particular the 
larger of the standard deviations given in Table 5. Although the latter 
conditional dispersion statistics cannot be interpreted as measures 
of global heterogeneity, some might appear greater than expected. 
Nevertheless, these are not incompatible with the ADC data 
provided by Bull et al., (2012), as obtained by averaging over the 
entire tumour44. They report that subject-specific PNET average 
ADC values lie in the interval 0.67 × 10–3 to 1.23 × 10–3 mm2 s–1, 
based on an examination of 22 cases.
As originally conceived, the main purpose of a simultaneous spa-
tial modelling analysis of core and boundary regions was improved 
parameter estimation. An initial working assumption was that 
the underlying random 2D spatial heterogeneity in the core and 
boundary regions would be similar, with the boundary-distance 
effect superimposed close to the boundary. Given a set of common 
spatial parameters, the information provided by the core would 
lead to improved precision in the boundary-specific parameter 
estimates. It became immediately obvious, however, that this pre-
liminary assumption was wrong and that the level of 2D spatial 
correlation in the core and boundary regions is distinguishable, 
regardless of the additional boundary-distance terms that were 
included in the model. The model was modified accordingly. 
Although the more general model does not offer the advantage of 
improved boundary parameter estimation based on information 
borrowed from the core, the precision of the resulting parameter 
estimates is nevertheless sufficient. In particular, a characterisation 
of the difference between the core and boundary regions is provided 
by the modified model, in addition to an estimate of the magnitude 
of the boundary-distance effect. In summary, the core and bound-
ary regions differ in their spatial correlation structure, requiring 
our initial model to be modified through the inclusion of region-
specific spatial random effect terms. Although this complicates the 
comparison of the boundary-distance effect with the underlying 
random 2D spatial heterogeneity, it is possible to obtain 
sufficiently precise estimates of the magnitude of these two 
sources of spatial variation.
A comment is required concerning the partial volume problem that 
arises in MRI due to finite resolution. Related issues include point 
spread function and zero filling effects. These must impact on the 
boundary distance coefficient estimates obtained in this study. For 
example, given the extreme case in which a step change occurs 
at the tumour boundary, partial volume/finite resolution effects, 
combined with image processing distortions, will cause a disper-
sion of the underlying step change in tissue characteristics. This 
interesting issue is related to the distinction between modelling the 
image-intensity data and modelling the underlying tissue structure. 
In keeping with standard practice among analysts engaged in MRI 
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post-processing work, the results presented in this paper are based 
on modelling the image intensity data. An alternative approach 
might be sought in which a latent variables model is constructed, 
aimed at capturing the unobserved underlying tissue structure, com-
bined with a model for the point spread function and zero-filling 
effects. A latent variables model must deal with all sources of image 
degradation. The resulting model will be complicated, however, and 
this will cause parameter estimation/precision problems, especially 
when working with sparse DWI data. A second point relates to the 
prognostic modelling literature that motivated this study. As stated 
in the Introduction, it has been suggested that PNET patient sur-
vival is a function of the tumour-boundary ADC gradient. Even in 
the extreme case in which a step change in tissue structure occurs 
at the tumour boundary, the magnitude of the gradient derived from 
the DW image will be related to the magnitude of the underlying 
step change. In particular, the magnitude of the ADC gradient will 
tend to zero as the step change tends to zero, and the relationship 
between them is expected to be monotonic. For this reason it is 
reasonable to assume that patient outcome will remain a function of 
any sensible regression coefficient derived from the tumour bound-
ary DWI data, despite the degradation cause by imaging constraints 
and data processing, if a relationship genuinely exists between the 
underlying structure and survival. Existing literature suggests that 
the DWI data carry prognostic information, despite image degrada-
tion. We do acknowledge that a comparison of a given boundary-
distance coefficient and the various measures of 2D heterogeneity 
is compromised, if the former is interpreted as a direct indicator 
of real underlying structure. For those readers preferring to dis-
miss the observed boundary decay in ADC as largely artefactual, 
caused by image degradation, we add the following rejoinder. The 
fact remains that the statistical model must include one or more 
terms to deal with the boundary effect, even if it is an imaging/
data-processing artefact. The boundary-distance coefficient will 
be a function of the magnitude of the assumed step change that 
occurs at the boundary, coupled with imaging effects. From this 
perspective, the boundary distance-effect statistics listed in Table 2 
and Table 4 might be regarded as measures of the magnitude of 
the imaging artefact, relative to the true 2D spatial heterogeneity 
in the region of the tumour boundary. We wish to stress that the 
notion of a tumour ADC dependence on boundary distance is not 
ours, and the main purpose of this study was to determine whether 
the boundary effect disappears after adjusting for an underlying 
2D spatial heterogeneity in ADC. The present statistical analysis 
is not compromised by the possibility that the ADC boundary- 
distance effect is partly artefactual. The statistical model applies to 
the image data as opposed to the underlying structure. As it hap-
pens, the distance effect remains statistically significant, regard-
less of its origin. An additional note is warranted. This paper does 
not address any issues arising from the assertion that tumour ADC 
provides a reliable biomarker of cellularity, apart from the state-
ments made in the Introduction regarding the limitations of simple 
correlation analyses and the criteria that should be met before 
claiming to have a reliable surrogate marker.
Model assessment and posterior predictive simulation
Posterior predictive simulation was performed as a mechanism for 
assessing model adequacy. In essence this is a simulation approach 
to comparing an observed statistic, designed to capture some 
key feature of the data, with that given by the model (chapter 6 
in 23,41–43). Bayesian p-values are commonly adopted as a meas-
ure of discrepancy between an observed statistic and that obtained 
under the model. We note that the approach has received some criti-
cism. For example, the predictive probabilities are not calibrated 
(in general, the posterior predictive p-values do not have a uniform 
distribution under the null hypothesis45). Some data analysts have 
suggested that the very notion of Bayesian p-values is a contradic-
tion. (An indication of the nature of the paradox is given on page 
87 of 28.) A number of eminent statisticians remain enthusiastic 
about this approach to model evaluation, however. The early BUGS 
documentation46 included a section on goodness-of-fit tests based 
on Bayesian p-values. Gelman, who is a notable advocate, argues 
that a statistical model can seldom be perfectly true (see page 158 
in 23, or page 776 in 42), but that it is important to demonstrate 
that it is adequate for the intended purpose, even if it is deficient in 
some other aspect. Posterior predictive simulation provides a useful 
tool for performing this kind of model assessment. Nevertheless, 
we acknowledge that controversy remains regarding some aspects 
of this approach, including the calibration issue referred to above 
and an uncertainty regarding the p-value threshold that is used to 
indicate a problem. Thus the simple analysis adopted in the present 
study is undertaken without reference to the expected distribution 
under a satisfactory model. The purpose is to verify that there are 
not too many instances where an observation appears unexpected 
under the model. In the present study it was used as an approach for 
detecting potentially spurious signal intensities and/or instances of 
model failure, and to determine whether these are associated with 
extreme ADC estimates. We found two individual signal intensity 
observations with extremely low p-values. Given the nature of DWI 
and its sensitivity to movement, spurious observations might be 
expected. Thus, extremely low Bayesian p-values might be attrib-
uted to the simplicity of the error term, which ignores the possibil-
ity of spurious observations caused by motion and other imaging 
problems, as opposed to an inadequacy in the deterministic and/or 
spatial components of the model. That said, these two DWI obser-
vations did not give rise to extreme ADC estimates. Thus, exag-
gerated spatial heterogeneity measures arising from spurious DWI 
observations do not appear to be a problem. Accordingly, we con-
clude that the heterogeneity statistics given in this paper are robust 
to the presence of outlier signal intensities. Nevertheless, some 
might take the view that some form of model refinement should 
have been undertaken in an attempt to deal with the occurrence of a 
number of small Bayesian p-values. As a rejoinder we would argue 
that model assessment requires more comprehensive data than that 
provided by a standard clinical DWI acquisition. As stated previ-
ously, replication is desirable at several levels, including repeated 
acquisition within individual DWI datasets (as opposed to signal 
accumulation) and within-session DWI dataset replication. Given a 
reasonable level of replication, model refinement based on residuals 
analysis and other criteria becomes realistic. Furthermore, as stated 
above, replication at the DWI-dataset and/or imaging-session level 
would also facilitate an assessment of the robustness of the results.
Despite the limited number of observations per voxel and the result-
ing compromises, the signal intensity residuals were examined for 
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signs of model inadequacy, as a complement to the assessment that 
was performed using posterior predictive simulation. In addition 
to a small number of relatively large residuals which are attribut-
able to spurious signal intensity observations, the residual plots do 
display a degree of remaining spatial dependence. This does indicate a 
degree of model inadequacy, including a potential deficiency in the 
form of distance dependence that was adopted and/or the assump-
tions underlying the random effects. For example, the present 
random effects treatment is based on spatially invariant CAR 
precision parameters (these determine the level of local smooth-
ing), and this might be an oversimplification. A spatially adap-
tive model might be investigated, although this is not a trivial 
undertaking. Alternatively, the error term might be modified to cap-
ture the remaining spatial structure, thus dropping the independent 
residuals assumption and substituting some form of autoregressive 
error behaviour. In order to adopt the latter approach as a sensible 
solution, the magnitude of the residuals must remain small rela-
tive to the total spatial variation in signal amplitude, thus ensuring 
that the majority of the spatial variation is captured by the random 
effect and boundary effect terms. Restated, the spatial heterogeneity 
estimates derived from the analyses will be compromised if a sub-
stantial proportion of the intra-tumour variation is captured by the 
error term. A heavy-tailed error distribution might provide a mecha-
nism for dealing with spurious observations arising from a sensi-
tivity to motion. Clearly, the model that was adopted in this study 
cannot be regarded as definitive. As stated above, model assessment 
and refinement, including an examination of the assumptions under-
lying the error term, would be facilitated by data replication. In 
particular, a comprehensive dataset with replication would permit a 
meaningful examination of alternative boundary decay models.
A final comment on the form of the model used in this study relates 
to the decision to adopt CAR priors for the spatial random effect 
terms. As stated in the Results section, the CAR prior precision 
parameters cannot be used as direct measures of global tumour het-
erogeneity because these relate to local spatial correlation struc-
ture as opposed to global structure. Trial analyses were performed 
using a global model of spatial heterogeneity based on so-called 
exchangeable priors. This would have offered the advantage of 
providing more direct measures of heterogeneity. Unfortunately, 
this model tended to produce poorly distributed residuals due to 
over-fitting, a problem that might be expected given the lack of 
replicate signal intensity observations and poor coverage of the 
b-value range. For this reason, given the present data, models based 
on exchangeable priors were abandoned as a potential alternative to 
the present CAR-prior models.
The preceding qualifications regarding the validity of the spatial 
model and/or error term prompt us to make a final comment regard-
ing the value of this study. The question is whether it was sensible 
to embark on a study using clinical data that are sub-optimum from 
a modelling perspective. In our view, the paediatric data available 
to us represent a valuable and rare resource, despite the limitations 
arising from the acquisition constraints of a standard clinical imag-
ing environment. We suggest that using these data in an exploratory 
study is justified, and provides a valid mechanism for gaining insight 
into the utility of the information that might be derived from these 
data. There is no possibility of re-scanning these children using an 
experimental imaging protocol for the sole purpose of undertak-
ing an exploratory study of the potential benefits of a given kind 
of analysis. The results obtained from this preliminary study using 
existing data gives an indication of the possibilities, enabling a deci-
sion to be made regarding the development of this approach. A clear 
indication of the manner in which the imaging protocol might be 
improved also emerges, although any proposed changes are subject 
to the constraints that inevitably arise in a clinical setting. We have 
shown that despite the limitations of an analysis based on standard 
clinical DWI data (mainly a lack of replication), the heterogene-
ity summary measures have sufficient precision to be useful. The 
spatial model does achieve a separation of the noise contribution 
from the effects of departure from mono-exponential dependence, 
despite the absence of replication in the b0 signal intensity obser-
vation. The constraints imposed by the CAR spatial prior and the 
spatially invariant error distribution render the problem tractable. 
The key is a simultaneous modelling of a collection of voxels, since 
the separate estimation of the true signal intensity and noise contri-
butions to a single b0 observation is impossible in an independent-
voxels analysis. A comparison of the ADC estimates (both ADCs 
and ADC0.5) obtained with the current spatial model and a simple 
voxel-by-voxel fitting of the DWI signal intensity data (treating 
the b0 observations as error free) indicates marked differences in 
some voxels, which is expected and attributable to the shrinkage/ 
smoothing properties of the random effects model.
Tumour boundary detection and related issues
Another matter that requires attention is ROI selection. In this study 
boundary ROIs were positioned where the tumour border is very 
well defined, working under the assumption that boundary effects 
might be more pronounced in that region. More sophisticated 
approaches should be investigated if the models outlined in this 
paper are to be adopted for prognostic modelling. Apart from the 
practical issues of tumour segmentation and automation, a modified 
approach will be required to cater for the expectation that tumour 
boundary heterogeneity is itself position dependent. Averaging 
heterogeneity over the entire boundary might obscure important 
prognostic information if, for example, tumour evolution is not 
uniform over the boundary. It would not be surprising to find 
improved performance among survival/prognostic models that 
retain position dependent heterogeneity information, compared 
with those based on averaged data or data taken from arbitrary 
regions.
Conclusion
In summary, the present study suggests that heterogeneity measures 
can be derived from standard clinical DWI datasets, despite their 
limited information content. Particular attention is paid to heteroge-
neity close to the tumour boundary, in order to determine whether 
water diffusivity in the boundary region of some tumours exhib-
its a deterministic dependence on distance from the boundary. The 
results indicate that the boundary-distance effect retains statistical 
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significance after adjusting for an underlying and general 2D spa- 
tial heterogeneity. The level of spatial heterogeneity in the region 
of the boundary is not consistently greater than that observed in 
the core. The analysis could be extended to determine whether the 
heterogeneity parameters provide useful prognostic indicators in a 
survival analysis. Obviously, the same approach could be adopted 
using data acquired with a purpose-designed sequence, the advan-
tage being that an increase in the accuracy and precision of the het-
erogeneity measures will be an advantage if these do carry useful 
prognostic information. In addition to assessing these heterogene-
ity measures as useful predictors in a survival analysis, the ques-
tion arises regarding the relationship between these measures and 
intra-tumour genetic spatial heterogeneity. A biomarker of genetic 
heterogeneity would provide a powerful tool with applications in 
both patient management and in cancer research. Clearly, any imag-
ing method that fulfils this role has the potential to provide clinical 
insights relevant to individual treatment and the pursuit of a better 
understanding of cancer biology.
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Supplementary Information
Note S1
Markov random field models and the conditional autoregres-
sive prior Markov random field models are well known among 
fMRI researchers, but a brief overview follows, as it applies to the 
present study. Markov processes are particularly prominent in time-
series data analysis. In that setting a first order Markov process is 
defined as a stochastic process in which the conditional probability 
of some future state is determined by the present state, unaffected by 
past history. Thus the process is first order autoregressive (AR(1)) 
given by X
t
 = αX
t–1 + Zt (see, for example, page 35 in 47) where Zt 
is some random process with zero mean (X
t
 is the autoregressive 
process). An extension of this kind of conditional independence 
to the spatial case leads to Markov random field models in which 
the probability distribution of a random variable at some posi-
tion in space is completely determined by conditioning on a set of 
neighbouring values. Thus a Markov random field characteri-
sation of a spatial process is based on the assumption that the 
conditional distribution of some variable at a given location depends 
only on the value of this variable at a subset of immediately neigh-
bouring locations. In the present context, this is the prior assump-
tion, and it is modified by the information provided by the data, 
as expressed in the likelihood. The magnitude of the estimated 
differences between neighbouring voxels, ie., the extent to which 
the voxel-specific estimates are shrunk towards less extreme val-
ues, depends on the information content of the data, relative to the 
prior.
An intuitive Markov random field model, widely used as a prior 
distribution, is the intrinsic Gaussian conditional autoregressive 
(CAR) model which, for some parameter U, takes the form (see, for 
example, 24–26,31) 
                                   ≠ ∼ 2| , ( , / ),i v i u iU U i v N u w r                     (16)
where Ui|Uv is the probability distribution of Ui given Uv, the 
symbol ~ indicates ‘distributed as’, N(mean, variance) is the 
normal distribution with the specified conditional mean and 
conditional variance, ∈∂= ∑ 21 ,ii v uv
i
u u w
r  is a variance parameter, ri is 
the number of neighbours belonging to the ith voxel and ∂i denotes 
the set of voxel labels belonging to those voxels in the immediate 
neighbourhood of the ith voxel (i.e., those voxels sharing a corner 
or edge with the ith voxel); v belongs to that set. Thus, the prior 
conditional mean is the average of the neighbouring values. It hap-
pens that the conditional nature of this prior offers a considerable 
computational advantage in Bayesian analyses implemented using 
Markov chain Monte Carlo (MCMC). The CAR prior is adopted in 
the present work.
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Note S2
Convergence tests, simulation accuracy, posterior predictive 
simulation and Bayesian p-values 
Convergence tests
Convergence tests were performed as outlined in the Methods 
section. There were no instances in which the Gelman-Rubin diag-
nostic suggested convergence failure. The majority of the Geweke 
Z-scores were also satisfactory, although several chains yielded a 
Z-score above 2. In only one case was the Z-score extreme (a value 
of 4.4 was obtained for one of the 3 chains of the boundary-region 
ADCs range parameter in Subject 1). Despite these indications of 
some non-ideal Z-scores, a comparison of the parameter median 
estimates and 95% posterior intervals given by the individual 
chains indicated good agreement. Thus, we conclude that there is 
no instance of unreliable measures of heterogeneity caused by 
compromised convergence.
The Raftery-Lewis results indicated that in many cases 5000 sam-
ples (after thinning) were more than sufficient to provide the 0.025 
quantile estimates with an accuracy of ±0.005 with probability 
0.95. Thus the resulting nominal 95% credible intervals have a true 
coverage of between 94% and 96%, with probability 0.95. There 
were, however, many other instances where this level of simula-
tion accuracy was not achieved. Nevertheless, in these cases, the 
accuracy was at least ±0.01 with probability 0.95, which provides 
nominal 95% credible intervals with a true coverage of between 
93% and 97%, with probability 0.95. It should be noted that the 
heterogeneity statistics provided in this paper are generated after 
combining the three individual chains, and that the resulting 
accuracy will be greater than given here for the individual chains.
Posterior predictive simulation and Bayesian p-values
Model adequacy is of central importance to the present analy-
sis because an incapacity to capture the true DWI signal intensi-
ties is expected to give rise to meaningless measures of ADC 
heterogeneity. There were several instances where an observed 
DWI signal intensity appears extreme and the corresponding sig-
nal intensity estimate exhibits shrinkage towards a more typical 
value. This behaviour is expected under a random effects model, 
and is not necessarily an indication of model failure. Posterior 
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predictive simulation provides a mechanism for distinguishing 
between observations that are unexpected under the model (i.e., 
indicative of model failure), and observations that are compatible 
with the model despite appearing extreme. To this end, Bayesian 
p-values were calculated for every observation. The focus of this 
paper is tumour heterogeneity, as characterised by the extremes in 
ADC0.5 and ADCs. Thus, particular attention is paid to the Bayesian 
p-values obtained for those voxels that give rise to the extreme 
parameter values that determine each of the reported heterogene-
ity estimates (i.e., the various range statistics), noting that extreme 
signal-intensity observations do not necessarily give extreme ADC 
values, and vice versa. In three of the five cases, no observation 
yielded a Bayesian p-value less than 0.001. The exceptions were 
Subject 2 and 4, which, taken together, yielded a total of three 
p-values of approximately 6 × 10–4. These 2 cases yielded a number 
of additional observations with a p-value < 0.05, as did the other 3 
cases. Given the relatively large number of signal-intensity obser-
vations in each of the image datasets this is expected regardless 
of model adequacy. The largest number of observations with low 
p-values was obtained for Subject 1, with 20 p-values in the range 
0.001 < p-value < 0.01. Inspection of the raw signal intensity data 
and diffusion weighted images indicates that, in this particular 
case, a small image artefact contributes to the apparent discrepancy 
between the model and observed data. Focusing on those voxels 
with extreme ADC0.5 and ADCs values, as expected some voxels 
yield Bayesian p-values in the tails of the distribution (p-value 
< 0.05), but there are no instances where the p-value falls below 
0.01. This is consistent with the conclusion that the estimated ADC 
extremes are not invalid, i.e., attributable to the excessive influence 
of spurious signal intensity observations or model failure. In con-
trast, the model appears adequate in terms of its capacity to capture 
the true underlying tumour ADC heterogeneity. The low Bayesian 
p-values obtained for some observations do suggest, however, 
that potential improvements to the model might be sought. An 
inspection of various plots (not shown) indicates the presence of 
some spatial structure in the residuals. Thus, despite the appar-
ent complexity of the random effects model adopted in this study 
and the limited number of observations, just seven per voxel, the 
low Bayesian p-values obtained for some observations might 
indicate scope for model refinement. The Discussion takes up 
the model refinement issue.
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